Frankenfield Christopher James

CIK 00019883441 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001988344

Recent Transactions

31 trades

Sale
Xilio Therapeutics, Inc.$XLO
Common Stock
2026-01-02$0.64/sh−7,030→ 24,766 total
Exercise/Conversion
Xilio Therapeutics, Inc.$XLO
Common Stock
2026-01-01+19,375→ 31,796 total
Exercise/Conversion
Xilio Therapeutics, Inc.$XLO
Restricted Stock Units
2026-01-01−19,375→ 38,750 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-12-31+668,789→ 668,789 total
Disposition to Issuer
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−45,000→ 0 total
Disposition to Issuer
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−20,000→ 0 total
Disposition to Issuer
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−150,000→ 0 total
Disposition to Issuer
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−300,000→ 0 total
Disposition to Issuer
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−155,090→ 0 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+45,000→ 45,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+23,786→ 23,786 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+300,000→ 300,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+150,000→ 150,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−155,090→ 155,090 total
Disposition to Issuer
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−37,296→ 0 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+117,000→ 117,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+925,000→ 925,000 total
Disposition to Issuer
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−23,786→ 0 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+37,296→ 37,296 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21+20,000→ 20,000 total
Disposition to Issuer
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-11-21−117,000→ 0 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-04-15+75,000→ 75,000 total
Sale
Xilio Therapeutics, Inc.$XLO
Common stock
2025-01-02$0.98/sh−6,954→ 12,421 total
Exercise/Conversion
Xilio Therapeutics, Inc.$XLO
Common Stock
2025-01-01+19,375→ 19,375 total
Exercise/Conversion
Xilio Therapeutics, Inc.$XLO
Restricted Stock Units
2025-01-01−19,375→ 58,125 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-01-01+251,000→ 251,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2024-08-03+52,000→ 52,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2024-05-01+208,000→ 208,000 total
Award
Xilio Therapeutics, Inc.$XLO
Restricted Stock Units
2024-01-01+77,500→ 77,500 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2023-08-16+300,000→ 300,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (Right to Buy)
2023-08-03+150,000→ 150,000 total

Companies

Xilio Therapeutics, Inc.
Chief Financial Officer
$XLO

Recent Filings

Address

828 WINTER STREET SUITE 300

WALTHAM, MA, 02451

View on SEC.gov